We seed biomedical innovation

We accelerate the pace of innovation in biomedical research and drug discovery & development by combining the best of both worlds – academia and industry.

We seed biomedical innovation

and drug discovery in oncology, autoimmunity, and infectious diseases

Unlock deep immune insights and accelerate your discovery with T-FINDER.

T-FINDER – T cell Functional Identification and (Neo)-antigen Discovery of Epitopes and Receptors

Utilize our T-FINDER research platform to gain valuable insights while searching for your next solution. We specialize in a vital and intricate aspect of the human adaptive immune system: T lymphocytes. Our innovative, patent-pending platform is made up of three key components: the T-cell reporter construct, the Antigen-Presenting Cell construct, and the Phenotypic Screening Platform.

How can we support your research and development?

Profiling
Discovery

The T-FINDER platform is designed to functionally identify and map cognate epitopes to human T cell receptors (TCRs) with high speed and accuracy. It utilizes physiological antigen processing and T-cell activation processes.

TCR_MHC Clinically Tested Scientifically Tested Two-Way Scalability Scientifically Tested

Each T cell receptor (TCR) needs
T-Finder helps identify these pairs, making it easier to design new treatments, especially for cancer.

T-Finder helps identify these pairs, making it easier to design new treatments, especially for cancer.

Offers flexibility for multiple applications in immunotherapy.

Can determine the ligand for a given TCR or vice versa, creating a database of receptor-ligand pairs.

Introducing T-FINDER at the 6th TCR-Based Therapies Summit in Boston, April 2nd 2025

Presentation by Dr. John Lindner